diprosone
msd (pty) ltd - betamethasone dipropionate - topical ointment - betamethasone dipropionate 0,64 mg (equivalent to betamethasone 0.5mg per gram)
diprosone cream 0.05%
organon belgium, belgium - betamethasone dipropionate - cream - 0.05 %
diprosone ointment 0.05%
organon belgium, belgium - betamethasone dipropionate - ointment - 0.05 %
daivobet 50/500 ointment
leo pharma pty ltd - calcipotriol; betamethasone dipropionate -
daivobet 50/500 gel
leo pharma pty ltd - betamethasone dipropionate; calcipotriol -
daivobet 50/500 gel
leo pharma limited - betamethasone dipropionate 0.5 mg/g; ; calcipotriol 50 µg/g (as hydrate) - topical gel - 50 mcg - active: betamethasone dipropionate 0.5 mg/g calcipotriol 50 µg/g (as hydrate) excipient: butylated hydroxytoluene hydrogenated castor oil liquid paraffin nitrogen polyoxypropylene monostearyl ether tocoferols - topical treatment of scalp psoriasis
enstilar calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can
leo pharma pty ltd - calcipotriol, quantity: 20.5 microgram/g; betamethasone dipropionate, quantity: 264 microgram/g (equivalent: betamethasone, qty 205 microgram/g) - foam - excipient ingredients: polyoxypropylene-11 stearyl ether; liquid paraffin; dl-alpha-tocopherol; white soft paraffin; butane; methyl ether - enstilar is indicated for the topical treatment of psoriasis vulgaris in adults.
diprolene cream
merck canada inc - betamethasone (betamethasone dipropionate) - cream - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
diprolene lotion
merck canada inc - betamethasone (betamethasone dipropionate) - lotion - 0.05% - betamethasone (betamethasone dipropionate) 0.05% - anti-inflammatory agents
taro-mometasone lotion
taro pharmaceuticals inc - mometasone furoate - lotion - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents